PUBLICACIÓN
CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment
Almoguera B. et al.
2013 Pharmacogenetics and Genomics
Genetics (Q2), Genetics (clinical) (Q2), Molecular Biology (Q2), Molecular Medicine (Q2)
JCR: 3.45
SJR: 1.317
CITAS
31
DOI
10.1097/fpc.0b013e3283659a94
EID
2-s2.0-84886597555
ISSN
1744-6872
EISSN
1744-6880
BIBTEX
@article{Dorado2013,title = {CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment},journal = {Pharmacogenetics and Genomics},year = {2013},volume = {23},number = {11},pages = {627-630},author = {Almoguera, B. and Riveiro-Alvarez, R. and Lopez-Castroman, J. and Dorado, P. and Vaquero-Lorenzo, C. and Fernandez-Piqueras, J. and Llerena, A. and Abad-Santos, F. and Baca-Garc{\'i}a, E. and Dal-R{\'e}, R. and Ayuso, C.}}
AUTORES DE LA UEX